![At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high‐risk leukemias - Norell - 2013 - Journal of Leukocyte Biology - Wiley Online Library At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high‐risk leukemias - Norell - 2013 - Journal of Leukocyte Biology - Wiley Online Library](https://jlb.onlinelibrary.wiley.com/cms/asset/c723a25f-710c-47d4-9fcc-70721d3264ed/jlb.2013.94.issue-6.cover.jpg?trick=1665245211612)
At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high‐risk leukemias - Norell - 2013 - Journal of Leukocyte Biology - Wiley Online Library
![At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high‐risk leukemias - Norell - 2013 - Journal of Leukocyte Biology - Wiley Online Library At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high‐risk leukemias - Norell - 2013 - Journal of Leukocyte Biology - Wiley Online Library](https://jlb.onlinelibrary.wiley.com/cms/asset/8eeb1ab7-504f-41c3-8c38-86438da3e08b/jlb1123-fig-0002-m.jpg)
At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high‐risk leukemias - Norell - 2013 - Journal of Leukocyte Biology - Wiley Online Library
![PDF) At the Bench: Preclinical rationale for exploiting NK cells and T lymphocytes for the treatment of high-risk leukemias PDF) At the Bench: Preclinical rationale for exploiting NK cells and T lymphocytes for the treatment of high-risk leukemias](https://i1.rgstatic.net/publication/257599652_At_the_Bench_Preclinical_rationale_for_exploiting_NK_cells_and_T_lymphocytes_for_the_treatment_of_high-risk_leukemias/links/56e69d3308ae98445c2243bc/largepreview.png)